Nicotine Vaccine
Riboflavin used for antibody-catalyzed oxidation of nicotine
Published in Vaccine Weekly, November 24th, 2004
"Tobacco abuse remains a major cause of death worldwide despite ample evidence linking nicotine to various disease states. Consequently, immunopharmacotherapeutic approaches for the treatment of nicotine abuse have received increasing attention. Although a number of nicotine-binding antibodies have been disclosed, no antibody catalysts exist which efficiently degrade nicotine into pharmacologically inactive substances," scientists writing in the journal Bioorganic and Medicinal Chemistry report.
"Herein, we report the first catalytic antibodies which can oxidatively...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-11-24)
More Articles from Vaccine Weekly
- AIDS/HIV Vaccine
Parenteral vaccine adjuvants promote mucosal anti-HIV immune responses - Anthrax Vaccine
Anthrax proteins associated with germination and outgrowth identified - Cancer Vaccine
Heat shock protein gp96 elicits anti-tumor CD8 T cell cytotoxicity - Meningococcal Vaccine
Putative vaccine antigens from Neisseria meningitidis identified - AIDS/HIV Vaccine
DNA vaccine elicits efficient CD8+ T cell response to HIV epitope - AIDS/HIV Vaccine
HIV-1 protease cleavage site in human C1-inhibitor identified - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
